Dimensional Fund Advisors’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.97M | Buy |
722,070
+78,232
| +12% | +$863K | ﹤0.01% | 2358 |
|
|
2025
Q1 | $5.75M | Buy |
643,838
+90,125
| +16% | +$805K | ﹤0.01% | 2459 |
|
|
2024
Q4 | $5.21M | Buy |
553,713
+95,304
| +21% | +$897K | ﹤0.01% | 2519 |
|
|
2024
Q3 | $3.69M | Buy |
458,409
+128,228
| +39% | +$1.03M | ﹤0.01% | 2611 |
|
|
2024
Q2 | $2.8M | Buy |
330,181
+91,679
| +38% | +$777K | ﹤0.01% | 2672 |
|
|
2024
Q1 | $2.14M | Buy |
238,502
+105,318
| +79% | +$945K | ﹤0.01% | 2780 |
|
|
2023
Q4 | $1.5M | Buy |
133,184
+61,564
| +86% | +$692K | ﹤0.01% | 2849 |
|
|
2023
Q3 | $617K | Buy |
71,620
+16
| +0% | +$138 | ﹤0.01% | 3020 |
|
|
2023
Q2 | $741K | Buy |
+71,604
| New | +$741K | ﹤0.01% | 2985 |
|
|
2016
Q4 | – | Sell |
-43,018
| Closed | -$1.56M | – | 3301 |
|
|
2016
Q3 | $1.56M | Hold |
43,018
| – | – | ﹤0.01% | 2841 |
|
|
2016
Q2 | $976K | Sell |
43,018
-474
| -1% | -$10.8K | ﹤0.01% | 2931 |
|
|
2016
Q1 | $817K | Sell |
43,492
-30
| -0.1% | -$564 | ﹤0.01% | 2961 |
|
|
2015
Q4 | $713K | Buy |
43,522
+20,004
| +85% | +$328K | ﹤0.01% | 3028 |
|
|
2015
Q3 | $258K | Sell |
23,518
-1,088
| -4% | -$11.9K | ﹤0.01% | 3212 |
|
|
2015
Q2 | $320K | Sell |
24,606
-4,472
| -15% | -$58.2K | ﹤0.01% | 3199 |
|
|
2015
Q1 | $505K | Sell |
29,078
-27
| -0.1% | -$469 | ﹤0.01% | 3101 |
|
|
2014
Q4 | $434K | Sell |
29,105
-15
| -0.1% | -$224 | ﹤0.01% | 3154 |
|
|
2014
Q3 | $671K | Hold |
29,120
| – | – | ﹤0.01% | 3098 |
|
|
2014
Q2 | $929K | Buy |
+29,120
| New | +$929K | ﹤0.01% | 3051 |
|